Discover the latest trends in cell and gene therapies in our latest infographic @FrontageLabs and hear what our experts think in our panel discussion #BZcellgenetherapy https://t.co/zgP9hkxP8U
@LinusGroup@HamidGhanadan Love this insight and how it can be used to influence a technical audience. Also brings to mind 'Factfulness', an extremely interesting book that reveals the instincts that distort our perspective of global trends. https://t.co/r1XB3voMcG
It was a pleasure to interview @MSchwenkert last year. Check out his interview to discover how anti-idiotypic #antibodies can be used to develop #CAR-T cell #therapies @BioRadAbs @BioRadLifeSci https://t.co/GZiDfmJYjz
@LinusGroup@HamidGhanadan Thank you, I enjoyed this - a very helpful reminder of how a strategy or campaign can be structured to have the desired impact with this audience.
Join @BioRadAbs presentation on day 1 session 3 at @congress_ais#6AIS2018 to hear a case study demonstrating discovery and validation of a new target for a mAb in a mouse model, and learn how can you solve the problem of reagent antibody generation for self-antigens
Meet our custom antibody experts Ulrich and Michael at the Antibody Industrial Symposium in Montpellier next week (June 25-26), and find out what you could achieve with antibodies designed just for you @congress_ais#6AIS2018 @BioRadAbs
Meet our custom antibody experts Ulrich and Michael at the Antibody Industrial Symposium in Montpellier (June 25-26), and find out what you could achieve with antibodies designed just for you @congress_ais#6AIS2018
Interesting talk by Nisha Palackal @Regeneron#WRIB on their thorough reagent characterization methods to ensure consistent performance of bioanalytical assays. Typically 8-15 different reagents developed for each program.
Determining the identity of your critical reagents and developing robust assays will save you time n your drug development life cycle. Great presentation by Jonathan Haulenbeek @bmsinfo#WRIB